Alison M O'Neill from New York, NY, age 64

Alison Macleod O'Neill, Boston MA

view source

Specialties:

Neurology

Work:

Alison M Oneill, MD
466 Shawmut Ave, Boston, MA 02118
Sanofi
55 Cambridge Pkwy, Cambridge, MA 02142

Education:

University of Chicago (1990)

Alison Macleod O'Neill, Cambridge MA

view source

Specialties:

Neurologist

Address:

500 Kendall St, Cambridge, MA 02142
300 3Rd St, Cambridge, MA 02142

Vice President And Chief Counsel, M And A And Licensing

view source

Location:

New York, NY

Industry:

Pharmaceuticals

Work:

Pfizer
Vice President and Chief Counsel, M and A and Licensing
Skadden, Arps, Slate, Meagher & Flom Llp and Affiliates Oct 2000 - Jul 2006
Associate

Education:

New York University School of Law 1997 - 2000
Doctor of Jurisprudence, Doctorates, Law Georgetown University 1993 - 1997
Bachelors, Bachelor of Science, Politics

Languages:

Spanish

Agent And Administrator

view source

Industry:

Real Estate

Work:

Eovino & Associates
Agent and Administrator

Alison O'neill

view source

Location:

New York, NY

Industry:

Writing And Editing

Work:

Woulfe's Bookstore Oct 2016 - Jun 2017
Store Assistant
Tph-Project Services, Llc Sep 2016 - May 2017
Project Manager
The Kerryman Nov 2016 - Dec 2016
Journalist
Tph-Project Services, Llc Dec 2015 - Sep 2016
Communications Intern
Lazy Lanigans Jun 2013 - Sep 2013
Waitress

Education:

School of Food and Nutritional Sciences 2010 - 2015
Bachelors, Bachelor of Arts, English Language and Literature, Literature, English Language Queen's University Belfast 1991 - 2011
Masters, Master of Arts Tarbert Comprehensive School 2005 - 2010

Skills:

Public Speaking
Powerpoint
Customer Service
Driving License
Microsoft Word
Research
Teamwork
Literature
Social Media
Office Administration
English
Bartending
Writing
Communication
Presentations

Languages:

English

Senior Media Manager

view source

Location:

Allentown, PA

Industry:

Marketing And Advertising

Work:

Ardmore Advertising and Marketing
Senior Media Manager
Ardmore Advertising and Marketing Jun 2017 - Apr 2019
Media Manager
Lyle Bailie International May 2016 - Jun 2017
Media Planner and Buyer
Onsen Hot Pools Apr 2015 - Dec 2015
Customer Service Manager
Enterprise Rent-A-Car May 2011 - Apr 2015
Management Assistant

Education:

University of Strathclyde 2008 - 2012
Bachelors, Bachelor of Arts, Marketing, Management Omagh Academy

Skills:

Marketing
Social Media
Sales
Marketing Communications
Training
Leadership
Management
Team Leadership
Sales Prospecting
Social Media Marketing
Marketing Strategy
Online Advertising
Digital Marketing
Advertising
Digital Media
Media Planning
Media Buying
Presentations
Strategy
Iso Standards

Certifications:

Digital Essentials
Leadership and Management Level 2
Leadership and Management Level 3
Google Adwords Certified: Search
Cmi Level 5 Diploma In Leadership and Management

Managing Director

view source

Location:

New York, NY

Industry:

Management Consulting

Work:

Accenture since Aug 2007
Consultant

Education:

Columbia University in the City of New York 2003 - 2007

Skills:

Management Consulting

Certifications:

Safe Agilist (Sa)

Us Patents

Treatment Of Metastatic Tumors
view source
US Patent:

20090304592, Dec 10, 2009
Filed:

May 15, 2009
Appl. No.:

12/466599
Inventors:

Alison O'Neill - Boston MA, US
Douglas B. Jacoby - Wellesley MA, US
Abdellah Sentissi - Dover MA, US
Kamala Kesavan - West Roxbury MA, US
E. Michael Egan - Brookline MA, US
Laura Sen - Brookline MA, US
International Classification:

A61K 38/17
A61K 51/00
A61K 38/43
A61P 35/00
A61K 49/00
US Classification:

424 91, 514 25, 424 169, 424 941
Abstract:

The present invention is directed to methods and methods for the treatment, inhibition and/or reduction, and detection of metastatic tumors. In some embodiments, the inventive methods include systemic (e.g., intravenous) administration of a chlorotoxin agent that may or may not be labeled. In some embodiments, the inventive methods allow treatment, inhibition and/or reduction, and detection of metastases in the brain. In some embodiments, neovascularization is inhibited and/or newly formed vessels are caused to regress.

Systemic Administration Of Chlorotoxin Agents For The Diagnosis And Treatment Of Tumors
view source
US Patent:

20100215575, Aug 26, 2010
Filed:

Oct 10, 2008
Appl. No.:

12/682692
Inventors:

Alison O'Neill - Boston MA, US
Douglas B. Jacoby - Wellesley MA, US
Assignee:

TRANSMOLECULAR, INC. - Cambridge MA
International Classification:

A61K 51/08
A61K 38/17
A61K 38/43
A61K 49/00
A61P 35/00
US Classification:

424 169, 514 12, 424 943, 424 91, 424 96
Abstract:

The present invention is directed to methods and compositions for the treatment and diagnosis of neoplastic tumors. The inventive methods generally include systemic (e.g., intravenous) administration of a chloroxotoxin agent that may or may not be labeled.

Treatment Of Metastatic Tumors
view source
US Patent:

20130045163, Feb 21, 2013
Filed:

May 23, 2012
Appl. No.:

13/479203
Inventors:

Alison O'Neill - Cambridge MA, US
Douglas B. Jacoby - Wellesley MA, US
Abdellah Sentissi - Dover MA, US
Kamala Kesavan - West Roxbury MA, US
Laura Sen - Brookline MA, US
Assignee:

MORPHOTEK, INC. - EXTON PA
International Classification:

A61K 38/17
A61P 35/00
A61K 51/04
A61P 35/04
G01N 21/76
A61K 38/43
A61P 35/02
US Classification:

424 185, 424 941, 514 174, 435 75
Abstract:

The present invention is directed to methods and methods for the treatment, inhibition and/or reduction, and detection of metastatic tumors. In some embodiments, the inventive methods include systemic (e.g., intravenous) administration of a chlorotoxin agent that may or may not be labeled. In some embodiments, the inventive methods allow treatment, inhibition and/or reduction, and detection of metastases in the brain. In some embodiments, neovascularization is inhibited and/or newly formed vessels are caused to regress.

Methods Of Treating Cancer With An Anti-Cd39 Antibody
view source
US Patent:

20220389115, Dec 8, 2022
Filed:

Jun 1, 2022
Appl. No.:

17/829480
Inventors:

- Cambridge MA, US
Alison M. O'NEILL - Cambridge MA, US
Robert Ross - Cambridge MA, US
Assignee:

Surface Oncology, Inc. - Cambridge MA
International Classification:

C07K 16/28
A61P 35/00
A61K 39/395
A61K 45/06
A61K 31/7068
A61K 47/64
Abstract:

The invention provides methods of treating cancer using an anti-CD39 antibody or fragment thereof as monotherapy or in combination with other therapies at particular dosages and frequencies.

Anti-Cd39 Antibody Compositions And Methods
view source
US Patent:

20220372160, Nov 24, 2022
Filed:

Sep 15, 2020
Appl. No.:

17/642824
Inventors:

- Cambridge MA, US
Andrew LAKE - Westwood MA, US
Michael WARREN - North Chelmsford MA, US
Austin DULAK - Reading MA, US
Erik DEVEREAUX - Hanover MA, US
Pamela M. HOLLAND - Belmont MA, US
Tauqeer ZAIDI - Sharon MA, US
Matthew RAUSCH - Cambridge MA, US
Bianka Prinz - Lebanon NH, US
Nels P. NIELSON - Lebanon NH, US
Sonia DAS - Cambridge MA, US
Alison M. O'Neill - Cambridge MA, US
Assignee:

Surface Oncology, Inc. - Cambridge MA
International Classification:

C07K 16/28
A61P 35/00
Abstract:

The invention provides anti-CD39 antibody compositions and their use in treating cancer. In some embodiments, an isolated anti-CD39 antibody is provided. Such an isolated anti-CD39 antibody binds to human CD39, wherein the antibody is optionally fully human or humanized. In some embodiments, the disclosure provides a method of enhancing, increasing and/or sustaining an anti-tumor immune response in a subject comprising administering the antibody or composition described herein to a subject having a tumor.